The suppression of DUSP5 expression correlates with paclitaxel resistance and poor prognosis in basal-like breast cancer

Basal-like breast cancer (BLBC) is resistant to endocrinotherapy and targeted therapy and new molecular therapies are needed for BLBC. In this study, we evaluated the role of DUSP1 and DUSP5, negative regulators of mitogen-activated protein kinase pathway, in the aggressiveness of BLBC. MDA-MB-231 c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tieju, Sun, Huizhi, Liu, Shiqi, Yang, Zhao, Li, Linqi, Yao, Nan, Cheng, Siqi, Dong, Xueyi, Liang, Xiaohui, Chen, Chen, Wang, Yi, Zhao, Xiulan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001410/
https://www.ncbi.nlm.nih.gov/pubmed/29910679
http://dx.doi.org/10.7150/ijms.24981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001410/
https://www.ncbi.nlm.nih.gov/pubmed/29910679
http://dx.doi.org/10.7150/ijms.24981

Ejemplares similares